Due to its fast kinetics, TCO/Tt cycloaddition was used in this study for the in situ conjugation of the components of a two-component, two-step drug delivery system in a HER2(+) human breast cancer mouse model, as shown in Fig. 1. The gene discussed is ERBB2; the disease is breast cancer.